This company has been acquired
EMHT.F Stock Overview
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Emerald Health Therapeutics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.041 |
| 52 Week High | CA$0.086 |
| 52 Week Low | CA$0.02 |
| Beta | 0.63 |
| 1 Month Change | 35.00% |
| 3 Month Change | 6.92% |
| 1 Year Change | -49.38% |
| 3 Year Change | -89.05% |
| 5 Year Change | -97.80% |
| Change since IPO | -89.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| EMHT.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 19.5% | -1.5% | -3.2% |
| 1Y | -49.4% | 9.7% | 19.3% |
Return vs Industry: EMHT.F underperformed the US Pharmaceuticals industry which returned 4% over the past year.
Return vs Market: EMHT.F underperformed the US Market which returned -21.4% over the past year.
Price Volatility
| EMHT.F volatility | |
|---|---|
| EMHT.F Average Weekly Movement | 21.2% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EMHT.F's share price has been volatile over the past 3 months.
Volatility Over Time: EMHT.F's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 111 | n/a | emeraldhealth.ca |
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015.
Emerald Health Therapeutics, Inc. Fundamentals Summary
| EMHT.F fundamental statistics | |
|---|---|
| Market cap | US$5.62m |
| Earnings (TTM) | -US$21.20m |
| Revenue (TTM) | US$5.36m |
1.0x
P/S Ratio-0.3x
P/E RatioIs EMHT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMHT.F income statement (TTM) | |
|---|---|
| Revenue | CA$7.13m |
| Cost of Revenue | CA$12.67m |
| Gross Profit | -CA$5.54m |
| Other Expenses | CA$22.64m |
| Earnings | -CA$28.18m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | -77.71% |
| Net Profit Margin | -395.33% |
| Debt/Equity Ratio | 0% |
How did EMHT.F perform over the long term?
See historical performance and comparison